Logo image of SXTC

CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Price, Forecast & Analysis

USA - NASDAQ:SXTC - VGG2161P1577 - Common Stock

1.41 USD
+0.04 (+2.92%)
Last: 11/10/2025, 1:58:33 PM

SXTC Key Statistics, Chart & Performance

Key Statistics
Market Cap163.60M
Revenue(TTM)1.74M
Net Income(TTM)-3.30M
Shares116.03M
Float75.04M
52 Week High7.84
52 Week Low0.95
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-3.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2019-01-04
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


SXTC short term performance overview.The bars show the price performance of SXTC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

SXTC long term performance overview.The bars show the price performance of SXTC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SXTC is 1.41 USD. In the past month the price decreased by -7.28%. In the past year, price decreased by -64.9%.

CHINA SXT PHARMACEUTICALS IN / SXTC Daily stock chart

SXTC Latest News, Press Relases and Analysis

SXTC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO43.8911.62B
JNJ JOHNSON & JOHNSON18.08452.07B
MRK MERCK & CO. INC.9.82216.01B
PFE PFIZER INC7.58137.93B
BMY BRISTOL-MYERS SQUIBB CO7.1895.83B
ZTS ZOETIS INC18.852.82B
RPRX ROYALTY PHARMA PLC- CL A9.422.53B
VTRS VIATRIS INC4.311.69B
ELAN ELANCO ANIMAL HEALTH INC23.211.07B
CORT CORCEPT THERAPEUTICS INC85.077.89B
AXSM AXSOME THERAPEUTICS INCN/A6.94B
LGND LIGAND PHARMACEUTICALS28.484.07B

About SXTC

Company Profile

SXTC logo image China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.

Company Info

CHINA SXT PHARMACEUTICALS IN

178 Taidong Road North

Taizhou JIANGSU 225300 CN

CEO: Feng Zhou

Employees: 75

SXTC Company Website

SXTC Investor Relations

Phone: 8652386298290

CHINA SXT PHARMACEUTICALS IN / SXTC FAQ

What does CHINA SXT PHARMACEUTICALS IN do?

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.


Can you provide the latest stock price for CHINA SXT PHARMACEUTICALS IN?

The current stock price of SXTC is 1.41 USD. The price increased by 2.92% in the last trading session.


Does CHINA SXT PHARMACEUTICALS IN pay dividends?

SXTC does not pay a dividend.


How is the ChartMill rating for CHINA SXT PHARMACEUTICALS IN?

SXTC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is CHINA SXT PHARMACEUTICALS IN (SXTC) stock traded?

SXTC stock is listed on the Nasdaq exchange.


Can you provide the ownership details for SXTC stock?

You can find the ownership structure of CHINA SXT PHARMACEUTICALS IN (SXTC) on the Ownership tab.


SXTC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SXTC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SXTC. While SXTC seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SXTC Financial Highlights

Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of -3.01. The EPS increased by 97.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -15.25%
ROE -21.4%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-102.39%
Sales Q2Q%-7.84%
EPS 1Y (TTM)97.31%
Revenue 1Y (TTM)-9.73%

SXTC Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

SXTC Ownership

Ownership
Inst Owners0.07%
Ins Owners35.32%
Short Float %0.16%
Short Ratio0.34